Found: 113
Select item for more details and to access through your institution.
Potential use of RNA interference in cancer therapy.
- Published in:
- Expert Reviews in Molecular Medicine, 2010, v. 12, n. 1, p. 1, doi. 10.1017/S1462399410001584
- By:
- Publication type:
- Article
A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the baylor experience).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2000, v. 7, n. 8, p. 588, doi. 10.1007/BF02725338
- By:
- Publication type:
- Article
Defining the Cancer Master Switch.
- Published in:
- World Journal of Surgery, 2011, v. 35, n. 8, p. 1738, doi. 10.1007/s00268-010-0941-2
- By:
- Publication type:
- Article
Overview of the Development of Personalized Genomic Medicine and Surgery.
- Published in:
- World Journal of Surgery, 2011, v. 35, n. 8, p. 1693, doi. 10.1007/s00268-011-1056-0
- By:
- Publication type:
- Article
Personalized Cancer Approach: Using RNA Interference Technology.
- Published in:
- World Journal of Surgery, 2011, v. 35, n. 8, p. 1700, doi. 10.1007/s00268-011-1100-0
- By:
- Publication type:
- Article
FDA efficiency for approval process of COVID-19 therapeutics.
- Published in:
- Infectious Agents & Cancer, 2020, v. 15, n. 1, p. N.PAG, doi. 10.1186/s13027-020-00338-z
- By:
- Publication type:
- Article
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.
- Published in:
- Nature Medicine, 2000, v. 6, n. 8, p. 879, doi. 10.1038/78638
- By:
- Publication type:
- Article
Ovarian Cancer Immunotherapy and Personalized Medicine.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6532, doi. 10.3390/ijms22126532
- By:
- Publication type:
- Article
Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 894, doi. 10.3390/vaccines9080894
- By:
- Publication type:
- Article
Resident Memory T Cells and Their Effect on Cancer.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 562, doi. 10.3390/vaccines8040562
- By:
- Publication type:
- Article
p53 Gene Replacement for Cancer—Interactions with DNA Damaging Agents.
- Published in:
- Acta Oncologica, 2001, v. 40, n. 6, p. 739, doi. 10.1080/02841860152619160
- By:
- Publication type:
- Article
Nucleic acid aptamers for targeting of shRNAbased cancer therapeutics.
- Published in:
- Biologics: Targets & Therapy, 2007, v. 1, n. 4, p. 367
- By:
- Publication type:
- Article
TNFerade, an Adenovector Carrying the Transgene for Human Tumor Necrosis Factor α, for Patients With Advanced Solid Tumors: Surgical Experience and Long-Term Follow-Up.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2005, v. 12, n. 10, p. 825, doi. 10.1245/ASO.2005.03.023
- By:
- Publication type:
- Article
Head and neck cancer: Response to p53-based therapeutics.
- Published in:
- Head & Neck, 2011, v. 33, n. 1, p. 131, doi. 10.1002/hed.21364
- By:
- Publication type:
- Article
Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer.
- Published in:
- Oncology Reviews, 2023, p. 1, doi. 10.3389/or.2023.11471
- By:
- Publication type:
- Article
NF-KB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer.
- Published in:
- Oncology Reviews, 2022, v. 16, p. 1, doi. 10.3389/or.2022.10568
- By:
- Publication type:
- Article
In vivo Safety and Antitumor Efficacy of Bifunctional Small Hairpin RNAs Specific for the Human Stathmin 1 Oncoprotein.
- Published in:
- DNA & Cell Biology, 2011, v. 30, n. 9, p. 715, doi. 10.1089/dna.2011.1240
- By:
- Publication type:
- Article
RNA Profiling for Diagnosis and Prognosis of Human Cancer.
- Published in:
- DNA & Cell Biology, 2007, v. 26, n. 5, p. 293, doi. 10.1089/dna.2006.0554
- By:
- Publication type:
- Article
Effects of rifampin, itraconazole and esomeprazole on the pharmacokinetics of alisertib, an investigational aurora a kinase inhibitor in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 248, doi. 10.1007/s10637-017-0499-z
- By:
- Publication type:
- Article
Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 240, doi. 10.1007/s10637-017-0498-0
- By:
- Publication type:
- Article
Use of cytokines in the treatment of acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 1997, v. 11, p. S36
- By:
- Publication type:
- Article
PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0040452
- By:
- Publication type:
- Article
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 787, doi. 10.1007/s00262-014-1547-6
- By:
- Publication type:
- Article
BRCA1/2 Mutation Status Impact on Autophagy and Immune Response: Unheralded Target.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 6, p. 1, doi. 10.1093/jncics/pkaa077
- By:
- Publication type:
- Article
Advances in Targeted Therapy for the Treatment of Cervical Cancer.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 5992, doi. 10.3390/jcm12185992
- By:
- Publication type:
- Article
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.
- Published in:
- 1999
- By:
- Publication type:
- journal article
3D engineered scaffold for large-scale Vigil immunotherapy production.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65993-3
- By:
- Publication type:
- Article
Effect of CYP3A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 7, p. 1464, doi. 10.1111/bcp.13915
- By:
- Publication type:
- Article
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 3, p. 728, doi. 10.1111/bcp.12991
- By:
- Publication type:
- Article
Clonal Neoantigen: Emerging "Mechanism-based" Biomarker of Immunotherapy Response.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5616, doi. 10.3390/cancers15235616
- By:
- Publication type:
- Article
Preclinical Assessment of wt GNE Gene Plasmid for Management of Hereditary Inclusion Body Myopathy 2(HIBM2).
- Published in:
- Gene Regulation & Systems Biology, 2008, n. 2, p. 243, doi. 10.4137/GRSB.S728
- By:
- Publication type:
- Article
In vitro and in vivo growth suppression of MCF-7 human breast cancer by novel photoproducts and tamoxifen.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Shedding New Light on the Use of Imaging Technology for Glioblastoma Tumor Resection.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 7, p. 1136, doi. 10.1038/mt.2015.98
- By:
- Publication type:
- Article
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 6, p. 1103, doi. 10.1038/mt.2015.43
- By:
- Publication type:
- Article
Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 6, p. 1123, doi. 10.1038/mt.2015.14
- By:
- Publication type:
- Article
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 5, p. 1096, doi. 10.1038/mt.2013.32
- By:
- Publication type:
- Article
Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 11, p. 5382, doi. 10.1002/cam4.1703
- By:
- Publication type:
- Article
Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.645745
- By:
- Publication type:
- Article
Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.
- Published in:
- Frontiers in Physiology, 2014, v. 5, p. 1, doi. 10.3389/fphys.2014.00226
- By:
- Publication type:
- Article
Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.
- Published in:
- Frontiers in Physiology, 2014, v. 5, p. 1, doi. 10.3389/fphys.2014.00226
- By:
- Publication type:
- Article
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221994
- By:
- Publication type:
- Article
A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Homologous recombination proficiency in ovarian and breast cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Oncolytic viral therapies.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 10, p. 643, doi. 10.1038/sj.cgt.7700733
- By:
- Publication type:
- Article
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 10, p. 737, doi. 10.1038/sj.cgt.7700634
- By:
- Publication type:
- Article
Selectively replicating viral vectors.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 987, doi. 10.1038/sj.cgt.7700547
- By:
- Publication type:
- Article
Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-γ retroviral vector in melanoma patients.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 9, p. 1220, doi. 10.1038/sj.cgt.7700224
- By:
- Publication type:
- Article
Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma.
- Published in:
- Cancer Gene Therapy, 1999, v. 6, n. 4, p. 322, doi. 10.1038/sj.cgt.7700019
- By:
- Publication type:
- Article